Swiss specialty chemicals maker Clariant and U.S. group Huntsman abandoned their $20 billion merger on Friday, notching a win for activist investors who fought the deal for months on the grounds it would destroy shareholder value. More »
European shares hit their highest in nearly four months on Friday, helped by gains in Bayer after an asset sale deal paving the way for the German drugmaker's $66 billion acquisition of Monsanto. More »
We use cookies!
By using this site you agree to the use of cookies, more info.